ArticleCancer medicine2019

Killer immunoglobulin-like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment-free remission.

Pierre-Yves Dumas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.